r.wojcik
Submits third-party assay reports on material purchased directly. Based in Kumasi.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.88%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042105 | Retatrutide | TFC | TFC-2512-G7985 | Janoshik | 2026-Q2 | 98.41 | 1.88 | 105.2 | Supplier-supplied | 0 | PASS |
| AX-2026-043167 | BPC-157 | GL Biochem | GLBI-2602-T8420 | Janoshik | 2026-Q2 | 98.99 | 4.05 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041372 | Ipamorelin | WWB | WWB-2601-C3477 | VendorInvestigate | 2026-Q1 | 99.14 | 6.17 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020236 | MOTS-c | GGPeps | GGPE-2508-J1903 | PeptideMeter | 2025-Q4 | 98.56 | 4.88 | 103.7 | Supplier-supplied | 0 | PASS |
| AX-2025-020791 | Semaglutide | SGN | SGN-2502-J9961 | Janoshik | 2025-Q2 | 98.18 | 5.43 | 98.4 | Supplier-supplied | 2 | FAIL |
| AX-2024-004377 | Retatrutide | QSC | QSC-2404-P8297 | VendorInvestigate | 2024-Q2 | 98.78 | 6.13 | — | Buyer-sourced | 3 | MARGINAL |
| AX-2024-005033 | Humanin (HNG) | GGPeps | GGPE-2403-N2129 | Janoshik | 2024-Q2 | 99.22 | 3.41 | 103.6 | Supplier-supplied | 2 | FAIL |
| AX-2024-004872 | PT-141 (Bremelanotide) | SWB | SWB-2311-H6137 | Medutest | 2024-Q2 | 99.35 | 3.37 | — | Supplier-supplied | 0 | PASS |